Help shine a light on the battle against lung cancer
Talking about lung cancer – the signs, symptoms and effect it has on the lives of those living with the condition and their loved ones – is more important today than it has ever been. Lung cancer is not only the most common cancer in the world, it is also the leading cause of cancer death worldwide. In fact, the more than 1.5 million deaths around the world each year attributed to lung cancer are more than those related to colorectal, breast and prostate cancers combined.
Our commitment to addressing the needs of patients and caregivers impacted by this disease has never been stronger. Throughout the year, and during Lung Cancer Awareness Month, Bristol Myers Squibb works to provide access to care, empower patients and their loved ones through education and advance scientific research in lung cancer around the world.
Recognizing Caregivers and Addressing Disease Information Needs in the U.S.
In the U.S., we recognize the tremendous role caregivers and loved ones play in helping people with lung cancer manage their care. We also understand that finding the right information about the disease can be a challenge. We partnered with eight lung cancer patient advocacy groups in 2015 to create NavigateLungCancer.org, a one-stop-shop of information for patients and caregivers. We are also working to shed light on the experiences of those caring for people with lung cancer to better understand their needs.
Changing Disease Perceptions in the European Lung Cancer Community
There is a high prevalence of lung cancer in Europe and it is the number one cancer killer in that region of the world. We partnered with Lung Cancer Europe (LuCE) and actor Jack Huston on The Next Lung Cancer A.C.T. campaign to raise awareness and promote a dialogue aimed at humanizing the disease, dispelling stereotypes and encouraging people to learn about lung cancer. Through our partnership with LuCE, we have been able to spotlight patients and their supporters – sharing personal experiences of those who have gone through lung cancer with the hope of encouraging others to talk openly about the disease and patient needs.